Ginkgo Bioworks Holdings, Inc. (DNA)

USD 8.36

(2.96%)

Total Liabilities Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual total liabilities in 2023 was 568.19 Million USD , down -29.25% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly total liabilities in 2024 Q2 was 792.18 Million USD , up 33.25% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported annual total liabilities of 803.04 Million USD in 2022, up 59.46% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported annual total liabilities of 503.61 Million USD in 2021, up 145.54% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly total liabilities of 594.49 Million USD for 2024 Q1, up 4.63% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly total liabilities of 568.19 Million USD for 2023 FY, down -29.25% from previous quarter.

Annual Total Liabilities Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Total Liabilities of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Total Liabilities Total Liabilities Growth
2023 568.19 Million USD -29.25%
2022 803.04 Million USD 59.46%
2021 503.61 Million USD 145.54%
2020 205.1 Million USD 4.93%
2019 195.46 Million USD 0.0%
2001 803.04 Million USD 0.0%

Peer Total Liabilities Comparison of Ginkgo Bioworks Holdings, Inc.

Name Total Liabilities Total Liabilities Difference
ADC Therapeutics SA 503.03 Million USD -12.953%
Alto Neuroscience, Inc. 158.3 Million USD -258.932%
Annovis Bio, Inc. 17.95 Million USD -3063.798%
Biohaven Pharmaceutical Holding Company Ltd. 85.23 Million USD -566.6%
Nuvation Bio Inc. 16.36 Million USD -3372.62%
Nuvation Bio Inc. 16.36 Million USD -3372.62%
Arcus Biosciences, Inc. 633 Million USD 10.239%
Zymeworks Inc. 116.07 Million USD -389.507%